Norelle C. Wildburger

University of Veterinary Medicine Hannover, Foundation — Germany

Medicine · Health Sciences

17h-index1.1kcitations28works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(10), Neuroscience and Neuropharmacology Research(4), Ion channel regulation and function(4), Advanced Proteomics Techniques and Applications(4), Cancer, Hypoxia, and Metabolism(4)

Publications28 total

Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
Frontiers in Cell and Developmental Biology·2020· 25 citedOpen Access
Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry
Journal of the American Society for Mass Spectrometry·2020· 119 citedOpen Access
SILK studies — capturing the turnover of proteins linked to neurodegenerative diseases
Nature Reviews Neurology·2019· 67 citedOpen Access
The structure of amyloid-β dimers in Alzheimer’s disease brain: a step forward for oligomers
Brain·2019· 4 citedOpen Access
P3‐071: <i>IN VIVO</i> STABLE ISOTOPE LABELING AND QUANTITATIVE MASS SPECTROMETRY IMAGING OF Aβ PLAQUE DEPOSITION AND TAUOPATHY IN HUMAN AD BRAIN
Alzheimer s & Dementia·2018· 1 cited
Environmental Enrichment and Social Isolation Mediate Neuroplasticity of Medium Spiny Neurons through the GSK3 Pathway
Cell Reports·2018· 53 citedOpen Access
Amyloid-β Plaques in Clinical Alzheimer’s Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity
Frontiers in Neurology·2018· 30 citedOpen Access
Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
Scientific Reports·2017· 161 citedOpen Access
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
Alzheimer s Research & Therapy·2017· 97 citedOpen Access
[P2–068]: SOLUBLE AMYLOID‐BETA AGGREGATES FROM HUMAN ALZHEIMER's DISEASE BRAINS
Alzheimer s & Dementia·2017
The driving regulators of the connectivity protein network of brain malignancies
2017· 7 cited
PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease
Experimental Neurology·2017· 41 citedOpen Access
MALDI-Imaging Mass Spectrometry of Brain Lipids
Neuromethods·2017· 5 cited
Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
Scientific Reports·2016· 125 citedOpen Access
P1‐100: Amyloid‐Beta (Aβ) Isoforms and Ptms of Soluble Aβ Oligomers from Human Brain
Alzheimer s & Dementia·2016Open Access
P1‐099: Purification and Quantitative Characterization of Amyloid‐Beta Oligomers from Alzheimer's Disease Brain Lysates
Alzheimer s & Dementia·2016Open Access
CK2 activity is required for the interaction of FGF14 with voltage‐gated sodium channels and neuronal excitability
The FASEB Journal·2016· 40 citedOpen Access
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts
Journal of Proteome Research·2015· 22 citedOpen Access
The proteomic landscape of glioma stem-like cells
EuPA Open Proteomics·2015· 12 citedOpen Access
Quantitative proteomics and transcriptomics reveals metabolic differences in attracting and non-attracting human-in-mouse glioma stem cell xenografts and stromal cells
EuPA Open Proteomics·2015· 6 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Cheryl F. Lichti(9), Randall J. Bateman(8), Fernanda Laezza(7), Carol L. Nilsson(7), Thomas J. Esparza(6), David L. Brody(6), Miroslav N. Nenov(6), Nigel J. Cairns(5), Alexander S. Shavkunov(5), Richard D. LeDuc(3), Hao Jiang(3), Thomas F. James(3), Thomas A. Green(3), Jim Hsu(3), Ekaterina Mostovenko(3), Mark R. Emmett(3), A.K. Singh(3), Jai S. Rudra(3), Joy Gumin(3), Roger A. Kroes(3)